Search

Search Constraints

You searched for: Author/Creator Jacob, A.

Search Results

4. Acalabrutinib vs Rituximab Plus Idelalisib (IdR) or Bendamustine (BR) by Investigator Choice in Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia: Phase 3 ASCEND Study. (12th June 2019)

6. Monitoring of Dust Devil Tracks Around the InSight Landing Site, Mars, and Comparison With In Situ Atmospheric Data. Issue 10 (16th May 2020)

7. P668: ACALABRUTINIB VS RITUXIMAB PLUS IDELALISIB OR BENDAMUSTINE IN RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: ASCEND RESULTS AT ~4 YEARS OF FOLLOW-UP. (23rd June 2022)

8. The Polarization of Ambient Noise on Mars. Issue 1 (6th January 2021)